Case Study: The ADAPTABLE Study

A multi-site, patient-centered clinical trial studying the two most common aspirin doses for cardiovascular disease.

October 12, 2021

Duke CTSI announces the publication of a new case study documenting the multi-site ADAPTABLE Study with Duke PIs Adrian Hernandez, MD, and W. Schuyler Jones, MD. This patient-centered clinical trial studied the effectiveness and safety of the two most common aspirin doses for cardiovascular disease.

Find out how the project was designed and carried out, see a timeline of the steps involved, and learn the results in this detailed, but accessible, case study.

Designed with both laypeople and academic researchers in mind, the case study includes:

  • Overview of the project
  • Research team composition
  • Timeline of funding and commercialization milestones
  • Institutional resources used
  • Summary of benefits

Download the case study here (PDF).

This is the second installment in a series of case studies using the Translational Science Benefits Model (TSBM) framework, which reveals the path of a research project from idea to impact.


About the TSBM: The Translational Science Benefits Model is a framework public health and clinical scientists can use to demonstrate the impact of their work in the real world.